Objectives The aim of this study (PROSPERO ID: CRD42017081952) was to evaluate
medical treatment for epistaxis from hereditary hemorrhagic telangiectasia (HHT). Data …

Background Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant
hereditary disorder resulting in vascular dysplasia and formation of arteriovenous …

Abstract Purpose of Review To analyze and compare the effects of epistaxis treatments for
Hereditary Hemorrhagic Telangiectasia (HHT) patients. Recent Findings Of total of 21 …

Background: There are currently no guidelines in the UK for the specific management of
hereditary haemorrhagic telangiectasia related epistaxis. The authors aimed to review the …

Background Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant
disease affecting 1 in 5000 individuals. Epistaxis is seen in more than 90% of patients with …

Objectives: Hereditary hemorrhagic telangiectasia (HHT) is a common inherited condition
characterized by mucosal telangiectasias, recurrent epistaxis, and arteriovenous …

BackgroundHereditary haemorrhagic telangiectasia is an autosomal dominant condition,
characterised by mucocutaneous telangiectasia, aneurysm and arteriovenous …

Objectives/Hypothesis To identify factors influencing the severity of epistaxis in hereditary
hemorrhagic telangiectasia (HHT). Study Design Participants with and without HHT were …

Purpose Hereditary hemorrhagic telangiectasia (HHT) is a vascular disorder that presents
with recurrent, intractable epistaxis. The aim of this study was to retrospectively analyze the …

Hereditary hemorrhagic telangiectasia is a rare vascular genetic disease. Epistaxis is the
most frequent and disabling manifestation, and timolol appears to be a new therapeutic …